Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$25.68
0.090.35%
Last update: Dec 18, 9:46 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Zymeworks (ZYME) stock?
You can purchase shares of Zymeworks (NASDAQ:ZYME) through any online brokerage.
Who are Zymeworks (ZYME) competitors?
Other companies in Zymeworks’s space includes: Immunome Inc (NASDAQ:IMNM), Twist Bioscience Corp (NASDAQ:TWST), Sarepta Therapeutics Inc (NASDAQ:SRPT), Syndax Pharmaceuticals Inc (NASDAQ:SNDX) and Mesoblast Ltd (NASDAQ:MESO).
What is the forecast, or price target, for Zymeworks (ZYME) stock?
Zymeworks has a consensus price target of $25.13.
What is the current price for Zymeworks (ZYME)?
The stock price for Zymeworks (NASDAQ: ZYME) is $25.68 last updated December 18, 2025 at 9:46 AM EST.
Does Zymeworks (ZYME) pay a dividend?
There are no upcoming dividends for Zymeworks.
When is Zymeworks (NASDAQ:ZYME) reporting earnings?
Zymeworks does not have any upcoming earnings scheduled.
Is Zymeworks (ZYME) going to split?
There is no upcoming split for Zymeworks.
What sector and industry does Zymeworks (ZYME) operate in?
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
